Revenue during the quarter grew 3.66 percent to $883.44 million from $852.29 million in the previous year period.

Cost of revenue went up marginally by 2.79 percent or $10.05 million during the quarter to $369.72 million. Gross margin for the quarter expanded 35 basis points over the previous year period to 58.15 percent.

Operating margin for the quarter expanded 363 basis points over the previous year period to 29.29 percent.

Revenue from real estate activities during the quarter increased 3.98 percent or $33.03 million to $862.82 million.

Income from operating leases during the quarter rose 10.21 percent or $36.60 million to $395.22 million.

Income from management fees during the quarter plunged 52.60 percent or $3.78 million to $3.41 million. Revenue from other real estate activities during the quarter was almost stable at $464.19 million, when compared with the previous year period.

Other income during the quarter was $20.63 million, down 8.34 percent or $1.88 million from year-ago period.

"The year is off to an excellent start, as we delivered strong results on the back of attractive property performance in the first quarter,” said Debra A. Cafaro, Ventas chairman and chief executive officer. "These results were achieved while executing on our strategic priorities of enhancing our liquidity and financial profile, making excellent investments, increasing our development and redevelopment pipeline and executing successfully in the capital markets. Notably, we scaled our leading university-based research and life science platform, adding state-of-the-art facilities and expanding our partnerships with top research universities, and funded Ardent’s acquisition of high-quality acute care hospitals to expand its business to $3 billion in annual revenues.

The company has spent $1,034.06 million cash to meet investing activities during the quarter as against cash outgo of $166.75 million in the last year period.

Cash flow from financing activities was $503.08 million for the quarter as against cash outgo of $111.84 million in the last year period.

Cash and cash equivalents stood at $91.28 million as on Mar. 31, 2017, up 76.56 percent or $39.58 million from $51.70 million on Mar. 31, 2016.

Receivables increase substantially
Net receivables were at $1,398.42 million as on Mar. 31, 2017, up 39.48 percent or $395.82 million from year-ago.

Total assets grew 7.45 percent or $1,658.04 million to $23,919.33 million on Mar. 31, 2017. On the other hand, total liabilities were at $13,264.07 million as on Mar. 31, 2017, up 6.98 percent or $865.05 million from year-ago.

Return on assets moved up 9 basis points to 1.11 percent in the quarter. At the same time, return on equity moved up 35 basis points to 1.89 percent in the quarter.